Fexofenadine/pseudoephedrine

Last updated

Fexofenadine/pseudoephedrine
Combination of
Fexofenadine Antihistamine
Pseudoephedrine Nasal decongestant
Clinical data
Trade names Allegra-D
MedlinePlus a601053
License data
Pregnancy
category
  • AU:B2
Routes of
administration 		By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

Fexofenadine/pseudoephedrine, sold under the brand name Allegra-D among others, is a fixed-dose combination medication used for the treatment of nasal congestion and other symptoms of allergies [4] and the common cold. [2] It contains fexofenadine, as the hydrochloride, an antihistamine; and pseudoephedrine, as the hydrochloride, a nasal decongestant. [2]

In 2021, it was the 279th most commonly prescribed medication in the United States, with more than 800,000 prescriptions. [5] [6]

References

  1. ↑ "Allegra-D Product information". Health Canada . 25 April 2012. Retrieved 2 June 2022.
  2. 1 2 3 "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 3 December 2020. Retrieved 2 June 2022.
  3. ↑ "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 30 August 2021. Retrieved 2 June 2022.
  4. ↑ Mansfield LE (May 2006). "Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis". Expert Opinion on Pharmacotherapy. 7 (7): 941–51. doi:10.1517/14656566.7.7.941. PMID   16634716. S2CID   23165002.
  5. ↑ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  6. ↑ "Fexofenadine; Pseudoephedrine - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.